TY - JOUR AU - Reese, A. C. AU - Whitson, J. M. AU - Meng, M. V. PY - 2013 DA - 2013// TI - Natural history of untreated renal cell carcinoma with venous tumor thrombus JO - Urol Oncol VL - 31 UR - https://doi.org/10.1016/j.urolonc.2011.12.006 DO - 10.1016/j.urolonc.2011.12.006 ID - Reese2013 ER - TY - JOUR AU - Blute, M. L. AU - Leibovich, B. C. AU - Lohse, C. M. AU - Cheville, J. C. AU - Zincke, H. PY - 2004 DA - 2004// TI - The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus JO - BJU Int VL - 94 UR - https://doi.org/10.1111/j.1464-410X.2004.04897.x DO - 10.1111/j.1464-410X.2004.04897.x ID - Blute2004 ER - TY - JOUR AU - Pouliot, F. AU - Shuch, B. AU - Larochelle, J. C. AU - Pantuck, A. AU - Belldegrun, A. S. PY - 2010 DA - 2010// TI - Contemporary management of renal tumors with venous tumor thrombus JO - J Urol VL - 184 UR - https://doi.org/10.1016/j.juro.2010.04.071 DO - 10.1016/j.juro.2010.04.071 ID - Pouliot2010 ER - TY - JOUR AU - Hirono, M. AU - Kobayashi, M. AU - Tsushima, T. AU - Obara, W. AU - Shinohara, N. AU - Ito, K. PY - 2013 DA - 2013// TI - Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-447 DO - 10.1186/1471-2407-13-447 ID - Hirono2013 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. AU - Srinivas, S. PY - 2015 DA - 2015// TI - Nivolumab versus Everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - JOUR AU - Borregales, L. D. AU - Adibi, M. AU - Thomas, A. Z. AU - Wood, C. G. AU - Karam, J. A. PY - 2016 DA - 2016// TI - The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma JO - Ther Adv Urol VL - 8 UR - https://doi.org/10.1177/1756287215612962 DO - 10.1177/1756287215612962 ID - Borregales2016 ER - TY - JOUR AU - Cost, N. G. AU - Delacroix, S. E. AU - Sleeper, J. P. AU - Smith, P. J. AU - Youssef, R. F. AU - Chapin, B. F. PY - 2011 DA - 2011// TI - The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2011.02.032 DO - 10.1016/j.eururo.2011.02.032 ID - Cost2011 ER - TY - JOUR AU - Bigot, P. AU - Fardoun, T. AU - Bernhard, J. C. AU - Xylinas, E. AU - Berger, J. AU - Rouprêt, M. PY - 2014 DA - 2014// TI - Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? JO - World J Urol VL - 32 UR - https://doi.org/10.1007/s00345-013-1088-1 DO - 10.1007/s00345-013-1088-1 ID - Bigot2014 ER - TY - JOUR AU - Robert, G. AU - Gabbay, G. AU - Bram, R. AU - Wallerand, H. AU - Deminière, C. AU - Cornelis, F. PY - 2009 DA - 2009// TI - Complete histologic remission after Sunitinib neoadjuvant therapy in T3b renal cell carcinoma JO - Eur Urol VL - 55 UR - https://doi.org/10.1016/j.eururo.2008.12.036 DO - 10.1016/j.eururo.2008.12.036 ID - Robert2009 ER - TY - JOUR AU - Motzer, R. J. AU - Tannir, N. M. AU - McDermott, D. F. AU - Arén Frontera, O. AU - Melichar, B. AU - Choueiri, T. K. PY - 2018 DA - 2018// TI - Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1712126 DO - 10.1056/NEJMoa1712126 ID - Motzer2018 ER - TY - JOUR AU - Bindayi, A. AU - Hamilton, Z. A. AU - McDonald, M. L. AU - Yim, K. AU - Millard, F. AU - McKay, R. R. PY - 2018 DA - 2018// TI - Neoadjuvant therapy for localized and locally advanced renal cell carcinoma JO - Urol Oncol VL - 36 UR - https://doi.org/10.1016/j.urolonc.2017.07.015 DO - 10.1016/j.urolonc.2017.07.015 ID - Bindayi2018 ER - TY - JOUR AU - Chapin, B. F. AU - Delacroix, S. E. AU - Culp, S. H. AU - Nogueras Gonzalez, G. M. AU - Tannir, N. M. AU - Jonasch, E. PY - 2011 DA - 2011// TI - Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.05.032 DO - 10.1016/j.eururo.2011.05.032 ID - Chapin2011 ER - TY - JOUR AU - Gyorki, D. E. AU - Yuan, J. AU - Mu, Z. AU - Zaidi, B. AU - Pulitzer, M. AU - Busam, K. PY - 2013 DA - 2013// TI - Immunological insights from patients undergoing surgery on Ipilimumab for metastatic melanoma JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-013-2999-1 DO - 10.1245/s10434-013-2999-1 ID - Gyorki2013 ER - TY - JOUR AU - Kurta, J. M. AU - Thompson, R. H. AU - Kundu, S. AU - Kaag, M. AU - Manion, M. T. AU - Herr, H. W. PY - 2009 DA - 2009// TI - Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size? JO - BJU Int VL - 103 UR - https://doi.org/10.1111/j.1464-410X.2008.07941.x DO - 10.1111/j.1464-410X.2008.07941.x ID - Kurta2009 ER - TY - JOUR AU - Chiou, V. L. AU - Burotto, M. PY - 2015 DA - 2015// TI - Pseudoprogression and immune-related response in solid tumors JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.61.6870 DO - 10.1200/JCO.2015.61.6870 ID - Chiou2015 ER - TY - JOUR AU - Schaaf, M. B. AU - Garg, A. D. AU - Agostinis, P. PY - 2018 DA - 2018// TI - Defining the role of the tumor vasculature in antitumor immunity and immunotherapy JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-017-0061-0 DO - 10.1038/s41419-017-0061-0 ID - Schaaf2018 ER - TY - JOUR AU - López, J. I. AU - Pulido, R. AU - Lawrie, C. H. AU - Angulo, J. C. PY - 2018 DA - 2018// TI - Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma JO - Ann Diagn Pathol VL - 34 UR - https://doi.org/10.1016/j.anndiagpath.2018.03.007 DO - 10.1016/j.anndiagpath.2018.03.007 ID - López2018 ER - TY - JOUR AU - Giraldo, N. A. AU - Becht, E. AU - Pagès, F. AU - Skliris, G. AU - Verkarre, V. AU - Vano, Y. PY - 2015 DA - 2015// TI - Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell Cancer JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2926 DO - 10.1158/1078-0432.CCR-14-2926 ID - Giraldo2015 ER - TY - JOUR AU - Mariathasan, S. AU - Turley, S. J. AU - Nickles, D. AU - Castiglioni, A. AU - Yuen, K. AU - Wang, Y. PY - 2018 DA - 2018// TI - TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25501 DO - 10.1038/nature25501 ID - Mariathasan2018 ER - TY - JOUR AU - Song, W. AU - Yeh, C. -. R. AU - He, D. AU - Wang, Y. AU - Xie, H. AU - Pang, S. -. T. PY - 2015 DA - 2015// TI - Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4478 DO - 10.18632/oncotarget.4478 ID - Song2015 ER - TY - JOUR AU - Jensen, H. K. AU - Donskov, F. AU - Marcussen, N. AU - Nordsmark, M. AU - Lundbeck, F. AU - Maase, H. PY - 2009 DA - 2009// TI - Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.9498 DO - 10.1200/JCO.2008.18.9498 ID - Jensen2009 ER - TY - JOUR AU - McDermott, D. F. AU - Huseni, M. A. AU - Atkins, M. B. AU - Motzer, R. J. AU - Rini, B. I. AU - Escudier, B. PY - 2018 DA - 2018// TI - Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0053-3 DO - 10.1038/s41591-018-0053-3 ID - McDermott2018 ER - TY - JOUR AU - Peng, W. AU - Chen, J. Q. AU - Liu, C. AU - Malu, S. AU - Creasy, C. AU - Tetzlaff, M. T. PY - 2016 DA - 2016// TI - Loss of PTEN promotes resistance to T cell-mediated immunotherapy JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-15-0283 DO - 10.1158/2159-8290.CD-15-0283 ID - Peng2016 ER - TY - JOUR AU - Lalani, A. -. K. A. AU - Xie, W. AU - Martini, D. J. AU - Steinharter, J. A. AU - Norton, C. K. AU - Krajewski, K. M. PY - 2018 DA - 2018// TI - Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0315-0 DO - 10.1186/s40425-018-0315-0 ID - Lalani2018 ER -